BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11751501)

  • 1. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi.
    Indsto JO; Cachia AR; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Dec; 7(12):4054-9. PubMed ID: 11751501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36.
    Poetsch M; Dittberner T; Woenckhaus C
    Oncogene; 2002 May; 21(19):3038-42. PubMed ID: 12082534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of heterozygosity targeting the inactive X chromosome in melanoma.
    Indsto JO; Nassif NT; Kefford RF; Mann GJ
    Clin Cancer Res; 2003 Dec; 9(17):6476-82. PubMed ID: 14695151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of clonality in melanocytic nevi.
    Hui P; Perkins A; Glusac E
    J Cutan Pathol; 2001 Mar; 28(3):140-4. PubMed ID: 11168766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus.
    Rübben A; Bogdan I; Grussendorf-Conen EI; Burg G; Böni R
    Recent Results Cancer Res; 2002; 160():100-10. PubMed ID: 12079204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma.
    Birindelli S; Tragni G; Bartoli C; Ranzani GN; Rilke F; Pierotti MA; Pilotti S
    Int J Cancer; 2000 Apr; 86(2):255-61. PubMed ID: 10738254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal melanocytomas: genetic comparison with uveal and dermal melanomas.
    Fogt F; Selim AM; Xu GX; Prinz MK; Eagle RC; Budimlija ZM
    Arch Ophthalmol; 2005 Mar; 123(3):377-80. PubMed ID: 15767481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9p21 deletions in primary melanoma.
    Naylor MF; Brown S; Quinlan C; Pitha JV; Evertt MA
    Dermatol Online J; 1997 Dec; 3(2):1. PubMed ID: 9452367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States).
    Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF
    Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel deletion Loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas.
    Hussein MR; Roggero E; Tuthill RJ; Wood GS; Sudilovsky O
    Arch Dermatol; 2003 Jun; 139(6):816-7. PubMed ID: 12810525
    [No Abstract]   [Full Text] [Related]  

  • 13. Classifying melanocytic tumors based on DNA copy number changes.
    Bastian BC; Olshen AB; LeBoit PE; Pinkel D
    Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
    Wang H; Presland RB; Piepkorn M
    Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
    Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
    IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
    Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
    Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions.
    D'Adda T; Candidus S; Denk H; Bordi C; Höfler H
    J Pathol; 1999 Nov; 189(3):394-401. PubMed ID: 10547602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma ex naevo: a study of the associated naevus.
    Bogdan I; Smolle J; Kerl H; Burg G; Böni R
    Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas.
    Hussein MR; Sun M; Roggero E; Sudilovsky EC; Tuthill RJ; Wood GS; Sudilovsky O
    Mol Carcinog; 2002 May; 34(1):35-44. PubMed ID: 12112321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas.
    Uribe P; Wistuba II; Gonzalez S
    Am J Dermatopathol; 2009 Jun; 31(4):354-63. PubMed ID: 19461239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.